Cambridge, United Kingdom

Michal Robert Matuszewski

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Nuclera Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michal Robert Matuszewski. Retrieved from https://idiyas.com/inventor/michal-robert-matuszewski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michal Robert Matuszewski: Advancing Nucleic Acid Synthesis.

Introduction

Michal Robert Matuszewski is an inventor associated with Nuclera Ltd. in Cambridge, Great Britain. His patent work concerns modified guanines and their potential use in nucleic acid synthesis.

Latest Patents

Matuszewski is associated with 1 patent, titled “Modified guanines.” The invention describes compounds represented by Formula (1a) or (1b), with specified substituents, and their use in methods of nucleic acid synthesis.

Career Highlights

His listed work connects him with Nuclera Ltd., a company focused on technologies related to biological research and synthesis. The patent reflects an interest in chemical compounds that may support the preparation of nucleic acids.

Collaborations

Matuszewski’s listed coworkers include Gordon Ross Mcinroy and Martin Edward Fox. Their shared association with the patent record highlights collaborative work in developing nucleic acid synthesis technologies.

Conclusion

Michal Robert Matuszewski’s patent on modified guanines represents his contribution to research into compounds and methods for nucleic acid synthesis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…